Article metrics

Download PDFPDF
Long-term follow-up confirms a survival advantage of the paclitaxel–cisplatin regimen over the cyclophosphamide–cisplatin combination in advanced ovarian cancer

 

Online download statistics by month:

Online download statistics by month: March 2019 to November 2021

AbstractFullPdf
Mar 20191600
Apr 20192400
May 20192501
Jun 2019702
Jul 20191100
Aug 20191600
Sep 2019400
Oct 20191201
Nov 2019700
Dec 2019700
Jan 20201000
Feb 2020900
Mar 20202500
Apr 20202100
May 20201700
Jun 20201900
Jul 20202600
Aug 2020900
Sep 20201400
Oct 20207600
Nov 20206000
Dec 20202301
Jan 20211505
Feb 20211500
Mar 20215601
Apr 20212200
May 2021801
Jun 2021200
Jul 2021200
Aug 2021200
Sep 2021200
Oct 20211200
Nov 20211900
Total593012